Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Hdac3 regulates lymphovenous and lymphatic valve formation
Harish P. Janardhan, Zachary J. Milstone, Masahiro Shin, Nathan D. Lawson, John F. Keaney Jr., Chinmay M. Trivedi
Harish P. Janardhan, Zachary J. Milstone, Masahiro Shin, Nathan D. Lawson, John F. Keaney Jr., Chinmay M. Trivedi
View: Text | PDF
Research Article Development Vascular biology

Hdac3 regulates lymphovenous and lymphatic valve formation

  • Text
  • PDF
Abstract

Lymphedema, the most common lymphatic anomaly, involves defective lymphatic valve development; yet the epigenetic modifiers underlying lymphatic valve morphogenesis remain elusive. Here, we showed that during mouse development, the histone-modifying enzyme histone deacetylase 3 (Hdac3) regulates the formation of both lymphovenous valves, which maintain the separation of the blood and lymphatic vascular systems, and the lymphatic valves. Endothelium-specific ablation of Hdac3 in mice led to blood-filled lymphatic vessels, edema, defective lymphovenous valve morphogenesis, improper lymphatic drainage, defective lymphatic valve maturation, and complete lethality. Hdac3-deficient lymphovenous valves and lymphatic vessels exhibited reduced expression of the transcription factor Gata2 and its target genes. In response to oscillatory shear stress, the transcription factors Tal1, Gata2, and Ets1/2 physically interacted with and recruited Hdac3 to the evolutionarily conserved E-box–GATA–ETS composite element of a Gata2 intragenic enhancer. In turn, Hdac3 recruited histone acetyltransferase Ep300 to form an enhanceosome complex that promoted Gata2 expression. Together, these results identify Hdac3 as a key epigenetic modifier that maintains blood-lymph separation and integrates both extrinsic forces and intrinsic cues to regulate lymphatic valve development.

Authors

Harish P. Janardhan, Zachary J. Milstone, Masahiro Shin, Nathan D. Lawson, John F. Keaney Jr., Chinmay M. Trivedi

×

Figure 6

Tal1, Gata2, and Ets1/2 recruit Hdac3 to the Gata2 intragenic enhancer in response to lymphatic shear stress.

Options: View larger image (or click on image) Download as PowerPoint
Tal1, Gata2, and Ets1/2 recruit Hdac3 to the Gata2 intragenic enhancer i...
(A) ChIP-qPCR analysis of Hdac3 recruitment to the Gata2 intragenic enhancer was performed in LECs subjected to static conditions or OSS. (B) Schematic model depicting TRANSFAC analysis of ENCODE ChIP-seq data sets at the E-box–GATA–ETS element of the Gata2 intragenic enhancer. (C) ChIP–qPCR analysis of Tal1, Gata2, and Ets1/2 recruitment to the Gata2 intragenic enhancer was performed in LECs. (D and E) Total lysates from pooled LECs subjected to static or OSS conditions were immunoprecipitated by IgG or Hdac3 antibody, and Western blot analysis was performed using Tal1, Gata2, or Ets1/2 antibody (D). Total Hdac3 and α-tubulin levels are shown as an input control (D). Tal1, Gata2, and Ets1/2 expression was quantified and normalized to total input using ImageJ software (E). (F) ChIP–qPCR analysis of Hdac3 recruitment to the Gata2 intragenic enhancer in scrambled shRNA–, Tal1 shRNA–, Gata2 shRNA–, or Ets1/2 shRNA–infected LECs subjected to OSS (n = 3). Data represent the mean ± SEM and are representative of 3 independent experiments. P values were determined by Student’s t test (C and F) or by 1-way ANOVA using Sidak’s multiple comparisons test (A and E). WB, Western blotting. See also Supplemental Figure 10.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts